These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35925737)

  • 21. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?
    Balsis S; Benge JF; Lowe DA; Geraci L; Doody RS
    Clin Neuropsychol; 2015; 29(7):1002-9. PubMed ID: 26617181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
    Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
    Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive phenotypes in Parkinson's disease: A latent profile analysis.
    Barvas E; Mattavelli G; Zappini F; Giardina F; Ottaviani D; Papagno C
    Neuropsychology; 2021 May; 35(4):451-459. PubMed ID: 34043394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of Multidomain Interventions With Improvements in Cognition in Mild Cognitive Impairment: A Systematic Review and Meta-analysis.
    Salzman T; Sarquis-Adamson Y; Son S; Montero-Odasso M; Fraser S
    JAMA Netw Open; 2022 May; 5(5):e226744. PubMed ID: 35503222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations for interpreting failure on individual subtests of the Montreal Cognitive Assessment.
    Moafmashhadi P; Koski L
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):19-28. PubMed ID: 23385364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobar microbleeds are associated with a decline in executive functioning in older adults.
    Meier IB; Gu Y; Guzaman VA; Wiegman AF; Schupf N; Manly JJ; Luchsinger JA; Viswanathan A; Martinez-Ramirez S; Greenberg SM; Mayeux R; Brickman AM
    Cerebrovasc Dis; 2014; 38(5):377-83. PubMed ID: 25427958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies.
    Hampton OL; Mukherjee S; Properzi MJ; Schultz AP; Crane PK; Gibbons LE; Hohman TJ; Maruff P; Lim YY; Amariglio RE; Papp KV; Johnson KA; Rentz DM; Sperling RA; Buckley RF
    Neuropsychology; 2023 May; 37(4):436-449. PubMed ID: 35862098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Traceability and comparability through crosswalks with the NeuroMET Memory Metric.
    Melin J; Cano SJ; Gillman A; Marquis S; Flöel A; Göschel L; Pendrill LR
    Sci Rep; 2023 Mar; 13(1):5179. PubMed ID: 36997632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.
    Ramos AA; Galiano-Castillo N; Machado L
    Neuropsychol Rev; 2023 Dec; 33(4):659-674. PubMed ID: 36057684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harmonisation of later-life cognitive function across national contexts: results from the Harmonized Cognitive Assessment Protocols.
    Gross AL; Li C; Briceño EM; Arce Rentería M; Jones RN; Langa KM; Manly JJ; Nichols E; Weir D; Wong R; Berkman L; Lee J; Kobayashi LC
    Lancet Healthy Longev; 2023 Oct; 4(10):e573-e583. PubMed ID: 37804847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.